Literature DB >> 17171399

Heparin reduction with the use of cardiotomy suction is associated with hyperfibrinolysis during distal aortic perfusion with a heparin-coated semi-closed cardiopulmonary bypass system.

Norihiko Shiiya1, Kenji Matsuzaki, Takashi Kunihara, Hiroshi Sugiki.   

Abstract

We sought to elucidate the effects of different anticoagulation levels and the use of cardiotomy suction on the postoperative coagulatory and fibrinolytic systems in patients undergoing distal aortic perfusion using a fully heparin-coated (semi-)closed cardiopulmonary bypass (CPB) system incorporating a soft reservoir bag. Thirty-two patients were divided into two groups: those who underwent cardiotomy suction (S group, 18 patients) and those who did not (N group, 14 patients). We administered 1-2 mg/kg heparin in the S group, which achieved an activated clotting time (ACT) of 345 +/- 71 s. In the N group, we administered 0.7-1 mg/kg heparin, which achieved an ACT of 297 +/- 52 s. Data on platelet counts and serum levels of fibrinogen, antithrombin III, D-dimer, and fibrin degradation products (FDP) were collected, and factors influencing these variables were analyzed by multiple regression analysis. Both the patient group and the initial ACT level were independent factors influencing postoperative levels of FDP and D-dimer, whereas peak ACT level and the use of selective visceral/renal shunt/perfusion, but not the patient group, were independent factors influencing the postoperative platelet counts. In the S group, a significant inverse correlation was found between the ACT and levels of FDP or D-dimer, whereas no correlation was found in the N group. The use of cardiotomy suction was associated with elevated FDP and D-dimer levels even when a fully heparin-coated semi-closed CPB system was used. Lower ACT levels with the use of cardiotomy suction were associated with higher FDP and D-dimer levels, whereas such a relationship did not exist when cardiotomy suction was not used.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171399     DOI: 10.1007/s10047-006-0349-9

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  10 in total

1.  Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer.

Authors:  J A Young; C T Kisker; D B Doty
Journal:  Ann Thorac Surg       Date:  1978-09       Impact factor: 4.330

2.  Use of a soft reservoir bag in a fully heparin-coated closed-loop cardiopulmonary bypass system for distal aortic perfusion during aortic surgery.

Authors:  Norihiko Shiiya; Kenji Matsuzaki; Takashi Kunihara; Keishu Yasuda
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

3.  Significance of D-dimer concentrations during and after cardiopulmonary bypass.

Authors:  M E Comunale; J M Carr; R M Moorman; L K Robertson
Journal:  J Cardiothorac Vasc Anesth       Date:  1996-06       Impact factor: 2.628

4.  Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.

Authors:  N Tabuchi; J de Haan; P W Boonstra; W van Oeveren
Journal:  J Thorac Cardiovasc Surg       Date:  1993-11       Impact factor: 5.209

5.  Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects.

Authors:  N Mirow; T Brinkmann; K Minami; G Tenderich; K Kleesiek; R Körfer
Journal:  Artif Organs       Date:  2001-06       Impact factor: 3.094

6.  Perfusion with low systemic heparinization during resection of descending thoracic aortic aneurysms.

Authors:  L K von Segesser; B M Weiss; E Garcia; M Turina
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

7.  Reduction and elimination of systemic heparinization during cardiopulmonary bypass.

Authors:  L K von Segesser; B M Weiss; E Garcia; A von Felten; M I Turina
Journal:  J Thorac Cardiovasc Surg       Date:  1992-04       Impact factor: 5.209

8.  Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass.

Authors:  J H Chung; N Gikakis; A K Rao; T A Drake; R W Colman; L H Edmunds
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

9.  Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.

Authors:  E Ovrum; F Brosstad; E Am Holen; G Tangen; M Abdelnoor
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

10.  Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.

Authors:  G P Gravlee; W S Haddon; H K Rothberger; S A Mills; A T Rogers; V E Bean; D H Buss; D S Prough; A R Cordell
Journal:  J Thorac Cardiovasc Surg       Date:  1990-03       Impact factor: 5.209

  10 in total
  1 in total

1.  Journal of Artificial Organs 2006: the year in review.

Authors:  Y Sawa; T Horiuchi; A Kishida; T Masuzawa; M Nishimura; E Tatsumi; Y Tomizawa; H Watanabe
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.